Bruker vs Globus Medical
Bruker reported revenue of $3.4 billion in fiscal 2025, 1.2 times Globus Medical's $2.9 billion in fiscal 2025. Bruker's revenue grew 2.1% in its latest year, and Globus Medical's grew 16.6%. Bruker had an operating margin of 2.0%, against 16.3% at Globus Medical. Free cash flow was $43 million at Bruker and $589 million at Globus Medical.
Side by side
| Bruker | Globus Medical | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $3.4B | $2.9B |
| Revenue growth | 2.1% | 16.6% |
| Revenue growth a year, last 5 years | 11.6% | 30.1% |
| Gross margin | 45.9% | 67.4% |
| Operating margin | 2.0% | 16.3% |
| Net margin | −0.2% | 18.3% |
| Free cash flow | $43M | $589M |
| Free cash flow margin | 1.3% | 20.0% |
| Return on capital | 0.9% | 11.0% |
| Net debt to EBITDA | 5.5x | −0.7x |
| Dividends and buybacks | $33M | $300M |
| Change in diluted share count | 1.5% | −0.6% |
| Last close | $58.23 | $81.83 |
| P/E at the last close | — | 21.0× |
| Insider trades, last 12 months | sold $3.6 million | sold $17.5 million |
| Piotroski F-score | 4 of 9 | 9 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
BrukerGlobus Medical
Operating margin
Percent of revenue
BrukerGlobus Medical
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
BrukerGlobus Medical
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Bruker and Globus Medical pages.